Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h


+3226269640
Google maps


Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :
TAGS

11/02/2016
Survival and outcome analysis shows that selected HIV-positive patients are good candidates for liver and kidney transplant

Liver and kidney transplant can be justified for carefully selected HIV-positive patients, researchers from the United States show in AIDS . Transplant improved the chances of survival for HIV-positive patients with severe liver disease. Comparison with HIV-negative transplant patients showed that HIV-positive liver patients were more likely to experience organ rejection or die,...

Read more...

Source Source: Aidsmap





11/02/2016
Moderate alcohol consumption may be more harmful to people with HIV

Safe drinking limits for people living with HIV may be lower than the recommendations for the rest of the population, a large US cohort study suggests, especially in people not taking antiretroviral therapy. The findings are published by the journal Drug and Alcohol Dependence . The study findings indicate that only one country – the United Kingdom – is...

Read more...

Source Source: Aidsmap





11/02/2016
Does tenofovir (TDF) cause liver injury?

Tenofovir is an important antiviral drug used to treat HIV and hepatitis B virus and is made in two formulations: Tenofovir DF (tenofovir disoproxil fumarate; TDF) TAF (tenofovir alafenamide) The original formulation of tenofovir is TDF (Viread). This drug is in the following fixed-dose combinations: Truvada (tenofovir + FTC)...

Read more...

Source Source: CATIE





11/02/2016
Pharma company ViiV’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

New Delhi/Geneva, 10 February, 2016—People living with HIV have opposed patent applications in India for two important HIV medicines, dolutegravir and cabotegravir. Médecins Sans Frontières/Doctors Without Borders (MSF) supports these ‘patent oppositions,’ which have been filed to challenge an attempt by ViiV Healthcare (a joint venture by Pfizer and...

Read more...





11/02/2016
Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan : Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 280 of the “Global Fund Observer.” The newsletter features articles on various topics including the Board’s approval of 10 targets for key performance indicators for 2016; approved funding for $414 million in grants; and the...

Read more...